Literature DB >> 11707165

Residual neuropsychologic effects of cannabis.

H G Pope1, A J Gruber, D Yurgelun-Todd.   

Abstract

Acute intoxication with cannabis clearly produces cognitive impairment, but it is less clear how long cognitive deficits persist after an individual stops regular cannabis use. Numerous methodologic difficulties confront investigators in the field attempting to assess the residual neuropsychologic effects of cannabis among heavy users, and these must be understood to properly evaluate available studies. At present, it appears safe to conclude that deficits in attention and memory persist for at least several days after discontinuing regular heavy cannabis use. Some of these deficits may be caused or exacerbated by withdrawal effects from the abrupt discontinuation of cannabis; these effects typically peak after 3 to 7 days of abstinence. It is less clear, however, whether heavy cannabis use can cause neurotoxicity that persists long after discontinuation of use. It seems likely that such long-term effects, if they exist, are subtle and not clinically disabling--at least in the majority of cases.

Entities:  

Mesh:

Year:  2001        PMID: 11707165     DOI: 10.1007/s11920-001-0045-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  29 in total

1.  Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects.

Authors:  F A Struve; J J Straumanis; G Patrick; J Leavitt; J E Manno; B R Manno
Journal:  Drug Alcohol Depend       Date:  1999-10-01       Impact factor: 4.492

2.  A meta-analytic review of the relation between antisocial behavior and neuropsychological measures of executive function.

Authors:  A B Morgan; S O Lilienfeld
Journal:  Clin Psychol Rev       Date:  2000-01

3.  The relative contributions of ecstasy and cannabis to cognitive impairment.

Authors:  R J Croft; A J Mackay; A T Mills; J G Gruzelier
Journal:  Psychopharmacology (Berl)       Date:  2001-01       Impact factor: 4.530

4.  Cognitive correlates of long-term cannabis use in Costa Rican men.

Authors:  J M Fletcher; J B Page; D J Francis; K Copeland; M J Naus; C M Davis; R Morris; D Krauskopf; P Satz
Journal:  Arch Gen Psychiatry       Date:  1996-11

5.  Early and middle latency evoked potentials in medically and psychiatrically normal daily marihuana users: a paucity of significant findings.

Authors:  G Patrick; J J Straumanis; F A Struve; M J Fitz-Gerald; J E Manno
Journal:  Clin Electroencephalogr       Date:  1997-01

Review 6.  Pharmacology and effects of cannabis: a brief review.

Authors:  C H Ashton
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

7.  Prevalence of substance misuse in first-episode psychosis.

Authors:  R Cantwell; J Brewin; C Glazebrook; T Dalkin; R Fox; I Medley; G Harrison
Journal:  Br J Psychiatry       Date:  1999-02       Impact factor: 9.319

8.  Effects of chronic marijuana use on human cognition.

Authors:  R I Block; M M Ghoneim
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Short-term memory impairment in cannabis-dependent adolescents.

Authors:  R H Schwartz; P J Gruenewald; M Klitzner; P Fedio
Journal:  Am J Dis Child       Date:  1989-10

10.  Frontal-lobe cognitive dysfunction in conduct disorder adolescents.

Authors:  R J Lueger; K J Gill
Journal:  J Clin Psychol       Date:  1990-11
View more
  29 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  Effects of chronic marijuana use on brain activity during monetary decision-making.

Authors:  Jatin G Vaidya; Robert I Block; Daniel S O'Leary; Laura B Ponto; Mohamed M Ghoneim; Antoine Bechara
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Long-term effects of frequent cannabis use on working memory and attention: an fMRI study.

Authors:  Gerry Jager; Rene S Kahn; Wim Van Den Brink; Jan M Van Ree; Nick F Ramsey
Journal:  Psychopharmacology (Berl)       Date:  2006-03-07       Impact factor: 4.530

4.  A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.

Authors:  Barth Wilsey; Thomas Marcotte; Alexander Tsodikov; Jeanna Millman; Heather Bentley; Ben Gouaux; Scott Fishman
Journal:  J Pain       Date:  2008-04-10       Impact factor: 5.820

Review 5.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

Review 6.  Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.

Authors:  Florian Ganzer; Sonja Bröning; Stefanie Kraft; Peter-Michael Sack; Rainer Thomasius
Journal:  Neuropsychol Rev       Date:  2016-04-28       Impact factor: 7.444

7.  Effects of cannabis on cognitive function in patients with multiple sclerosis.

Authors:  Kimia Honarmand; Mary C Tierney; Paul O'Connor; Anthony Feinstein
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

8.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

Review 9.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

10.  Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory.

Authors:  Christopher D Verrico; Hong Gu; Melanie L Peterson; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2014-04       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.